Neoadjuvant treatment strategies for hepatocellular carcinoma

The incidence of hepatocellular carcinoma (HCC) remains high globally. Surgical treatment is the best treatment for improving the prognosis of patients with HCC. Neoadjuvant therapy plays a key role in preventing tumor progression and even downstaging HCC. The liver transplantation rate and resectab...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Lei, Chen, Lin, Zhang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727178/
https://www.ncbi.nlm.nih.gov/pubmed/35070063
http://dx.doi.org/10.4240/wjgs.v13.i12.1550
_version_ 1784626461845487616
author Xu, Lei
Chen, Lin
Zhang, Wei
author_facet Xu, Lei
Chen, Lin
Zhang, Wei
author_sort Xu, Lei
collection PubMed
description The incidence of hepatocellular carcinoma (HCC) remains high globally. Surgical treatment is the best treatment for improving the prognosis of patients with HCC. Neoadjuvant therapy plays a key role in preventing tumor progression and even downstaging HCC. The liver transplantation rate and resectability rate have increased for neoadjuvant therapy. Neoadjuvant therapy is effective in different stages of HCC. In this review, we summarized the definition, methods, effects, indications and contraindications of neoadjuvant therapy in HCC, which have significance for guiding treatment.
format Online
Article
Text
id pubmed-8727178
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-87271782022-01-20 Neoadjuvant treatment strategies for hepatocellular carcinoma Xu, Lei Chen, Lin Zhang, Wei World J Gastrointest Surg Review The incidence of hepatocellular carcinoma (HCC) remains high globally. Surgical treatment is the best treatment for improving the prognosis of patients with HCC. Neoadjuvant therapy plays a key role in preventing tumor progression and even downstaging HCC. The liver transplantation rate and resectability rate have increased for neoadjuvant therapy. Neoadjuvant therapy is effective in different stages of HCC. In this review, we summarized the definition, methods, effects, indications and contraindications of neoadjuvant therapy in HCC, which have significance for guiding treatment. Baishideng Publishing Group Inc 2021-12-27 2021-12-27 /pmc/articles/PMC8727178/ /pubmed/35070063 http://dx.doi.org/10.4240/wjgs.v13.i12.1550 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Review
Xu, Lei
Chen, Lin
Zhang, Wei
Neoadjuvant treatment strategies for hepatocellular carcinoma
title Neoadjuvant treatment strategies for hepatocellular carcinoma
title_full Neoadjuvant treatment strategies for hepatocellular carcinoma
title_fullStr Neoadjuvant treatment strategies for hepatocellular carcinoma
title_full_unstemmed Neoadjuvant treatment strategies for hepatocellular carcinoma
title_short Neoadjuvant treatment strategies for hepatocellular carcinoma
title_sort neoadjuvant treatment strategies for hepatocellular carcinoma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727178/
https://www.ncbi.nlm.nih.gov/pubmed/35070063
http://dx.doi.org/10.4240/wjgs.v13.i12.1550
work_keys_str_mv AT xulei neoadjuvanttreatmentstrategiesforhepatocellularcarcinoma
AT chenlin neoadjuvanttreatmentstrategiesforhepatocellularcarcinoma
AT zhangwei neoadjuvanttreatmentstrategiesforhepatocellularcarcinoma

Ejemplares similares